Physician profile
David E Lentz
NPI 1285625566
$2,352.94
in general payments reported to CMS, 2019-2025
23 companies · $264 in 2025
The $264 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $824 · 2020: $283 · 2021: $204 · 2022: $62.94 · 2023: $714 · 2025: $264.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $941 · Education: $37.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $941.11 |
| Education | $37.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,169.15 | 2019-2025 | Ozempic, Rybelsus |
| Bayer Healthcare Pharmaceuticals INC. | $178.34 | 2021-2023 | |
| Abbvie INC. | $150.48 | 2023 | |
| Stryker Corporation | $145.17 | 2019 | |
| Glaxosmithkline, LLC. | $85.94 | 2019-2023 | Arexvy |
| Astrazeneca Pharmaceuticals LP | $75.98 | 2019-2023 | Farxiga |
| Janssen Pharmaceuticals, INC | $68.69 | 2019 | |
| Lilly USA, LLC | $64.78 | 2022-2023 | Mounjaro |
| Pfizer INC. | $64.63 | 2019-2023 | |
| Baxter Healthcare | $64.50 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Exact Sciences Corporation | $48.64 | 2023 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.70 | 2025 | Jardiance |
| Corium, LLC | $36.84 | 2023 | Azstarys |
| Genzyme Corporation | $28.91 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $20.43 | 2023 | Trintellix |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.91 | 2020 | |
| Dynavax Technologies Corporation | $16.05 | 2023 | Heplisav-B |
| Allergan, INC. | $14.84 | 2020 | |
| Merck Sharp & Dohme LLC | $14.60 | 2023 | Vaxelis, Vaxneuvance, Gardasil 9 |
| Sanofi-Aventis U.S. LLC | $13.81 | 2019 | |
| Genentech USA, INC. | $12.36 | 2020 | |
| Shire North American Group INC | $11.75 | 2019 | |
| Amgen INC. | $11.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Lentz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.